Navigation Links
Kronos Announces First Quarter Business Update and Financial Results
Date:11/15/2007

pensation and benefits as a result of an increase in non cash compensation associated with the expensing of stock options and the expansion of Kronos' product development resources, a $79,000 increase in research and development expenses as Kronos invested in further improvements in the performance of its proprietary technology, and a $67,000 increase in professional services, partially offset by a $24,000 decrease in insurance expenses as a result of a reduction in directors and officers and general liability insurance costs. Interest expenses for the quarter ended September 30, 2007 was $435,000 compared to $99,000 for the corresponding period of the prior year. The increase in interest expense was principally the result of the amortization of the beneficial conversion feature of the new convertible debt financing obtained in June 2007.

Details of the Company's results can be found in its quarterly report filed November 14, 2007 on SEC Form 10-QSB, at http://www.sec.gov or at http://www.kronosati.com.

About Kronos Advanced Technologies, Inc.

Through its wholly-owned subsidiary, Kronos Air Technologies, Inc., Kronos Advanced Technologies has developed a new, proprietary air movement and purification system that utilizes state-of-the-art high voltage electronics and electrodes to silently move and clean air without any moving parts. Kronos is actively commercializing its technology for standalone and embedded products across multiple residential, commercial, and industrial markets. Kronos' technology is versatile, energy- and cost-efficient and exhibits multiple design attributes, creating a broad range of applications. Kronos' business strategy includes a combination of building internal capabilities, establishing strategic alliances and structuring licensing arrangements. Kronos Advanced Technologies is located in Belmont, MA. More information abou
'/>"/>

SOURCE Kronos Advanced Technologies, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/3/2015)... July 3, 2015  Obsidian HDS, the developer of ... service for the management of data on pharmaceutical and ... PharmaShine now includes the 2014 Open Payments General and ... on June 30. The data disclosed on Open Payments ... industry and providers totaling $6.49 billion and is the ...
(Date:7/2/2015)... TX and VANCOUVER , July ... "Company") (TSX-V: EPI) announced today that its common shares have ... Market ("NASDAQ") under the symbol "EPIX". ESSA will ... will retain its listing on the TSX Venture Exchange under ... listing of the common shares on the NASDAQ, each of ...
(Date:7/2/2015)... England , July 2, 2015 ... known as ,Friendly Aedes aegypti , , ... Juazeiro, Brazil by 95%, well ...      (Logo: http://photos.prnewswire.com/prnh/20150630/227348LOGO) , The journal ... a trial of Oxitec,s genetically engineered mosquitoes. The results ...
Breaking Medicine Technology:New Open Payments (Sunshine Act) Data Now Searchable on PharmaShine 2ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 2ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 3ESSA Pharma Inc. to Commence Trading on the NASDAQ Capital Market 4Oxitec Mosquito Works to Control Aedes aegypti in Dengue Hotspot 2Oxitec Mosquito Works to Control Aedes aegypti in Dengue Hotspot 3
(Date:7/3/2015)... ... 03, 2015 , ... On June 30th SEO authority and ... system called "Page One Engine" . The program, which has been hailed ... from several well-known marketers. HonestyFirstReviews.com's Tiffany Hendricks has joined the party, publishing an ...
(Date:7/3/2015)... ... 2015 , ... Scientists at several top US cancer centers believe they now ... Click here to read the complete story , just posted on the Surviving ... Medical Center, and New York University exposed mice with a mutation on the tumor ...
(Date:7/3/2015)... , ... July 03, 2015 , ... ... to healthcare providers, has been retained to lead a national president recruitment ... search firms in the healthcare industry, B. E. Smith has recently placed more ...
(Date:7/3/2015)... ... July 03, 2015 , ... ... on June 25, 2015 at 1:00pm. The Association welcomed speaker C. Daniel McGillicuddy ... injured bicyclists and practical points of investigating these types of cases. , Each ...
(Date:7/3/2015)... ... , ... Talcum powder attorneys representing clients in national lawsuits announce the launch ... website. Just as the previous version did, the new website will serve as a ... ovarian cancer warning information. The site is routinely updated with news articles on talcum ...
Breaking Medicine News(10 mins):Health News:Page One Engine - Review Of Dori Friend's SEO Training Course Released 2Health News:Study Finds Small Amounts of Asbestos May Trigger Mesothelioma in People with Genetic Mutation, According to Surviving Mesothelioma 2Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 2Health News:Regional Care, Inc. Retains B. E. Smith to Recruit New President 3Health News:Attorney from William Mattar Leads Discussion on Bicycle Accidents 2Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 2Health News:Talcum Powder Lawsuit News: Cancer Attorneys Launch Updated Mobile Site 3
... 21 Barr Pharmaceuticals, Inc. (NYSE: BRL ) ... to them relating to the acquisition of Barr by Teva ... , "Today,s vote demonstrated the ... Bruce L. Downey, Barr,s Chairman and CEO. "We are pleased ...
... a statewide survey, 33 physicians credentialed to practice at the Texas ... Texas Monthly in its 2008 annual listing of " ... year, the publishers of Texas Monthly work with Key ... the state of Texas to ask, "If you needed medical care, ...
... Nov. 21 Innerscope Research(TM), a revolutionary,biometric media ... the appointment of three executives who will strengthen ... , The ... of experience,include Geoffrey Gill as Chief Financial Officer ...
... Three Minnesotans who successfully,quit smoking will receive big prizes during ... 24 at the Xcel Energy Center. The winners,were participants in ... QUITPLAN(R) Services. , The ... runners-up,will get $1,000 gift cards from Gander Mountain. , ...
... needed less pain meds, study found , , FRIDAY, Nov. ... the amount of pain-killing medication requested by women during ... expectant mothers. , Half the women were assigned ... during their pregnancy, while the other half acted as ...
... cardiovascular disease are not given adequate drug therapy. This is ... of Deutsches rzteblatt International ( Dtsch Arztebl Int ... German results of this prospective, one-year survey. , 512 doctors ... patients in all, of whom 89.2% suffered from one or ...
Cached Medicine News:Health News:Barr Shareholders Approve Pending Teva Acquisition 2Health News:Barr Shareholders Approve Pending Teva Acquisition 3Health News:Barr Shareholders Approve Pending Teva Acquisition 4Health News:Annual List of 'Super Doctors' Features 33 Texas Institute for Surgery Physicians 2Health News:Innerscope Research Strengthens Management Team With Three Executive Appointments 2Health News:Lucky Quitters to Receive Big Money in Stop-Smoking Contest 2Health News:Aquarobics May Help Ease Labor 2
... The OTF5000 represents the new style ... long-established and reliable OTF/AS cryostat, the ... systems in the ever-reliable and powerful ... options plus money-saving package deals makes ...
... Leica TP1020 product family are semi-enclosed tissue ... combination of approved technology with modern and ... maximum safety for tissues at all stages ... based on proven precision mechanics in conjunction ...
... A unique sliding microtome with ... during return travel. Maintenance-free precision cross ... specimens and specialty applications in biological, ... up to 155 x 90 mm ...
... face-lifted Leica RM2125 microtome comes in two ... Leica RM2125 RT. All RM2125 versions are ... debris entering the precision micrometer feeding system. ... two-step trimming function and specimen retraction as ...
Medicine Products: